Literature DB >> 6542063

X-linked recessive myotubular myopathy: II. Muscle morphology and human myogenesis.

M W Ambler, C Neave, D B Singer.   

Abstract

The classification of centronuclear myotubular myopathies is controversial. Within this group of disorders, congenital X-linked recessive myotubular myopathy (XLMTM), characterized by marked cell hypotrophy and structural resemblance to fetal myotubes, represents a distinct entity. The histologic findings in verified and probable cases of XLMTM are reviewed. In addition, the ultrastructural features of muscle in one case of XLMTM are compared with those of normal fetal muscle at various developmental ages. In XLMTM both muscle and nerve show evidence of immaturity. Proliferation of the sarcotubular organelles in XLMTM, not observed in normal fetal muscle, may be due to impaired innervation.

Entities:  

Mesh:

Year:  1984        PMID: 6542063     DOI: 10.1016/s0046-8177(84)80305-6

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  9 in total

1.  Endplate structure and parameters of neuromuscular transmission in sporadic centronuclear myopathy associated with myasthenia.

Authors:  Teerin Liewluck; Xin-Ming Shen; Margherita Milone; Andrew G Engel
Journal:  Neuromuscul Disord       Date:  2011-04-08       Impact factor: 4.296

2.  In vivo imaging of skeletal muscle in mice highlights muscle defects in a model of myotubular myopathy.

Authors:  Luc Mercier; Johann Böhm; Nina Fekonja; Guillaume Allio; Yves Lutz; Marc Koch; Jacky G Goetz; Jocelyn Laporte
Journal:  Intravital       Date:  2016-04-06

3.  Fingerprint inclusions in normal fetal muscle.

Authors:  M W Ambler; C Neave; R Entwistle
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

4.  Severe neonatal asphyxia due to X-linked centronuclear myopathy.

Authors:  S E Braga; A Gerber; C Meier; A Weiersmüller; A Zimmermann; U Herrmann; S Liechti; H Moser
Journal:  Eur J Pediatr       Date:  1990-12       Impact factor: 3.183

5.  Myofiber size correlates with MTM1 mutation type and outcome in X-linked myotubular myopathy.

Authors:  Christopher R Pierson; Pankaj B Agrawal; Jessica Blasko; Alan H Beggs
Journal:  Neuromuscul Disord       Date:  2007-05-29       Impact factor: 4.296

6.  The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice.

Authors:  Anna Buj-Bello; Vincent Laugel; Nadia Messaddeq; Hala Zahreddine; Jocelyn Laporte; Jean-Francois Pellissier; Jean-Louis Mandel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

7.  Myotubular myopathy and the neuromuscular junction: a novel therapeutic approach from mouse models.

Authors:  James J Dowling; Romain Joubert; Sean E Low; Ashley N Durban; Nadia Messaddeq; Xingli Li; Ashley N Dulin-Smith; Andrew D Snyder; Morgan L Marshall; Jordan T Marshall; Alan H Beggs; Anna Buj-Bello; Christopher R Pierson
Journal:  Dis Model Mech       Date:  2012-05-24       Impact factor: 5.758

Review 8.  Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances.

Authors:  Raquel Gómez-Oca; Belinda S Cowling; Jocelyn Laporte
Journal:  Int J Mol Sci       Date:  2021-10-21       Impact factor: 5.923

Review 9.  Centronuclear myopathies under attack: A plethora of therapeutic targets.

Authors:  Hichem Tasfaout; Belinda S Cowling; Jocelyn Laporte
Journal:  J Neuromuscul Dis       Date:  2018
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.